Cirina

About:

At Cirina we are pioneering products that detect cancer at its earliest stages and empower you to take action.

Website: http://www.cirina.com

Twitter/X: cirinalabs

Top Investors: Decheng Capital

Description:

Cirina is developing innovative blood-plasma tests to detect deadly diseases at their earliest stages when curative treatments are most viable. The company is driven by the passion and life-long work of Co-founder and plasma nucleic acid pioneer, Dennis Lo, the first scientist to discover the presence of fetal DNA in a pregnant mother’s blood-plasma. Headquartered in South San Francisco, Calif., Cirina is currently actively recruiting top scientific and business talent to join its quest to detect devastating diseases like cancer at their earliest stages and empower people to take action. For more information, please visit http://cirinalabs.com.

Total Funding Amount:

$12M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New York, New York, United States

Founded Date:

2014-01-01

Contact Email:

joinus(AT)cirina.com

Founders:

Dennis Lo

Number of Employees:

11-50

Last Funding Date:

2016-10-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai